Trials / Sponsors / Marcela V. Maus, M.D.,Ph.D.
Marcela V. Maus, M.D.,Ph.D.
Academic / Other · 8 registered clinical trials — 6 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis Antineutrophil Cytoplasmic Antibody-associated Vasculitis | Phase 1 / Phase 2 | 2026-07-09 |
| Recruiting | Emapalumab Prevention of CAR-T Cell Associated Toxicities Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma | Phase 2 | 2024-09-18 |
| Recruiting | CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma | Phase 1 | 2023-10-26 |
| Recruiting | Long-term Follow-up of Subjects Treated With CAR T Cells Long Term Adverse Effects, CAR-T, Duty to Follow Up | — | 2023-08-07 |
| Recruiting | CARv3-TEAM-E T Cells in Glioblastoma Glioblastoma, Malignant Glioma, Recurrent Glioblastoma | Phase 1 | 2023-03-22 |
| Recruiting | TriPRIL CAR T Cells in Multiple Myeloma Multiple Myeloma, Multiple Myeloma in Relapse, Refractory Multiple Myeloma | Phase 1 | 2021-10-05 |
| Completed | A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma | Phase 2 | 2020-10-01 |
| Completed | CAR-37 T Cells in Hematologic Malignancies Hematologic Malignancy, Leukemia, Lymphoma | Phase 1 | 2020-06-19 |